Non-pathogenicE. colidisplaying decoy-resistant IL18 mutein boosts anti-tumor and CAR NK cell responses Article04 October 2024 Introduction Living bacterial therapeutics have reshaped the landscape of tumor immunotherapy,1,2with roots tracing back to the late 19th century when Dr. William Coley harne...